Innovative Drug Development for Diabetes
Ask AI about Innovative Drug Development for Diabetes
Post your question publicly — other visitors, and whoever manages this page, can answer. It will be visible on this page.
Want to hear about this company again? Follow it and we’ll email you when a new review appears.
AI-generated from reviews on this page. Verify anything important with the company directly.
Questions & Answers
No questions yet — be the first to ask.
Sign in to post
Your text is saved — you'll come right back to post.
Don't have an account? Create one
News & Press
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
About Innovative Drug Development for Diabetes
Endyra Therapeutics Inc. is a biopharmaceutical company dedicated to developing first-in-class drug therapies for type 2 diabetes mellitus and related chronic conditions such as fatty liver disease and NASH. The company focuses on creating innovative therapeutic interventions aimed at improving patient health outcomes and advancing chronic disease management. It is based in College Station, Texas, and can be reached by phone, email, or through a contact form on its website. The site also includes client testimonials related to its drug development work.
- Website
- endyratherapeutics.com
